ArticleThe European respiratory journal2019

Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.

Nishant Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.